Emory University

Mercer University

Union University

Howard University

E Blake Watkins

David K Brown

Jack Arbiser

J Phillip Bowen

Kathy Griendling

Bernard Lassegue

Amol Kulkarni

J Philip Bowen

Osman Güner

Qian Xu

This disclosure relates to compounds and methods of treating or preventing a Nox related disease or condition comprising administering to a subject in need thereof a Nox inhibitor or pharmaceutical compositions comprising a Nox inhibitor disclosed herein, derivatives, or compounds disclosed herein optionally substituted with one or more substitutes including optional salt and prodrug forms. In certain embodiments, this disclosure relates to sulfonylurea compounds and uses reported herein.

NADPH oxidase inhibitors and uses thereof

This disclosure relates to solenopsin derivatives, pharmaceutical compositions, and therapeutic uses related thereto. In certain embodiments, the disclosure relates to compounds of the following formula: 

Solenopsin and derivatives, therapeutic compositions; and methods related thereto

Growing community of inventors

Jackson, TN, United States of America

E Blake Watkins